•  
  •  
  •  
 

RNA Leaders

We focus on developing novel RNA-centered approaches to addressing unmet medical needs. SomaGenics' research and development has been supported by over $20M in competitive grants and it is our policy to publish the results of our efforts in respected peer-reviewed journals. Our staff includes internationally recognized leaders in RNA research and technology development. Learn more...

more about SomaGenics

Latest from SomaGenics

 

Rubicon Genomics Licenses Commercialization Rights from SomaGenics for Its RealSeq®-AC Technology for High-Throughput Sequencing of Small RNAs

Santa Cruz, Calif. July 28 2016- SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for...

Read more

Somagenics Presents Progress in Diabetic Wound Healing at the 10th RNA Consortium Meeting

Santa Cruz, CA, June 2016 -- In a talk at the City of Hope National Medical Center’s 10th RNA Consortium Meeting, held in Duarte, CA, Dr. Brian Johnston, CEO SomaGenics...

Read more

SomaGenics is a privately held biotech company with offices and laboratories located in Santa Cruz, CA. We specialize in small RNA technologies, including innovative RNAi-based therapeutics using sshRNA molecules, and diagnostics/biomarker detection of small or fragmented RNA, including microRNAs.

learn more